Literature DB >> 9470819

Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies.

D Edler1, H Blomgren, C J Allegra, P G Johnston, U Lagerstedt, I Magnusson, P Ragnhammar.   

Abstract

With the aid of specific monoclonal antibodies, an immunohistochemical technique has recently been developed for the detection of intratumoral thymidylate synthase (TS). This technique can be applied to paraffin-embedded material suitable for retrospective studies. In order to examine this technique further, the TS enzyme activity of lysates from frozen-stored colorectal cancer (CRC) specimens were compared with their immunohistochemical TS staining intensity (arbitrarily graded from 0 to 3). A statistically significant correlation between these two methods on a total of 25 tumour specimens (P < 0.001) was observed. The staining intensity in different areas of 48 paraffin-embedded CRCs was examined. Sixty-seven per cent of the tumours were homogeneously stained (either grades 0-1 or 2-3), 33% showed a heterogeneity in TS staining. Increased TS expression correlated with more advanced Dukes' stage (P < 0.001). It is concluded that TS immunostaining intensity reflects TS enzyme activity in colorectal tumours and is well suited for paraffin-embedded material. The TS immunostaining pattern is heterogeneous in up to one-third of the tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9470819     DOI: 10.1016/s0959-8049(97)00306-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

2.  Predictive and prognostic markers in colorectal cancer.

Authors:  Peter M Wilson; Robert D Ladner; Heinz-Josef Lenz
Journal:  Gastrointest Cancer Res       Date:  2007-11

3.  Prognostic and predictive value of thymidylate synthase expression in colon cancer.

Authors:  Gerasimos Tsourouflis; Stamatios E Theocharis; Anastasia Sampani; Athina Giagini; Alkiviadis Kostakis; Gregory Kouraklis
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

4.  Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.

Authors:  N A Wong; L Brett; M Stewart; A Leitch; D B Longley; M G Dunlop; P G Johnston; A M Lessells; D I Jodrell
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

5.  Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.

Authors:  A Paradiso; G Simone; S Petroni; B Leone; C Vallejo; J Lacava; A Romero; M Machiavelli; M De Lena; C J Allegra; P G Johnston
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

6.  New insights into the RNA-based mechanism of action of the anticancer drug 5'-fluorouracil in eukaryotic cells.

Authors:  Laura Mojardín; Javier Botet; Luis Quintales; Sergio Moreno; Margarita Salas
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.